10-Year Data Shows Accuray CyberKnife® System Provides Long-Lasting Relief of the Excruciating Pain Caused by Trigeminal Neuralgia

About this update from Accuray Incorporated

[{"type":"text","content":"Study Abstract Recognized as Best Clinical Abstract at 2022 Radiosurgical Society Meeting\nSUNNYVALE, Calif., March 31, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that long-term follow-up data from a study of men and women with trigeminal neuralgia (TN) showed 72 percent continued to experience pain relief 10 years after receiving image-guided robotic radiosurgery treatments delivered with the CyberKnife® System. The study abstract, titled \"Robotic Image-Guided Radiosurgery for Trigeminal Neuralgia: Results after 10 Years,\" was recognized as Best Clinical Abstract at the recent 2022 Radiosurgical Society Meeting in Carlsbad, California.\n\n \n \n \n \n \n \n\n \nTN occurs most frequently in people over the age of 50 years old and is more common in women than in men [1]. A chronic pain condition affecting a craniofacial nerve that is primarily responsible for transmitting sensations from the face to the brain, TN is described by some patients as the most excruciating pain human beings can suffer. Pain can be brought on from the lightest of touches to the face, even a gently breeze can start a painful attack.\n\"Many people don't understand how debilitating the chronic pain associated with trigeminal neuralgia can be. If left untreated, or inadequately treated, it can be difficult to perform daily activities that most of us take for granted – from eating a meal, washing our face or brushing our teeth, to talking. That's why studies like this are so significant. They demonstrate that with treatment options like CyberKnife radiosurgery, we can provide our patients long-term pain control – without a rigid head frame, surgery or medications. We can offer our patients hope and the chance to once again focus on what's possible in their lives,\" said Alfredo Conti, associate professor of neurosurgery at Alma Mater Bologna University in Bologna, Italy.\nTN can affect patients over the course of their lives, making long-term medical care a necessity. Treatment of TN usually begins with medication to block the pain signals sent to the brain. Over time, some medications become less effective, and certain patients experience unpleasant side effects. Alternative treatments, such as injections, radiofrequency, balloon compression, surgery or radiosurgery, may be required for these patients.\n\"Clinical data conti...

More updates from Accuray Incorporated